Lv5
920 积分 2024-10-08 加入
Efficacy of ponatinib against ABL tyrosine kinase inhibitor-resistant leukemia cells
1个月前
已完结
Thrombotic microangiopathy as a cause of cardiovascular toxicity from the BCR-ABL1 tyrosine kinase inhibitor ponatinib
2个月前
已完结
Integrated Stress Response Potentiates Ponatinib-Induced Cardiotoxicity
2个月前
已完结
Modulating retinoid-X-receptor alpha (RXRA) expression sensitizes chronic myeloid leukemia cells to imatinib in vitro and reduces disease burden in vivo
3个月前
已完结
Design and Synthesis of Potent Retinoid X Receptor Selective Ligands That Induce Apoptosis in Leukemia Cells
4个月前
已完结
Targeting HDAC8 sensitizes tyrosine kinase inhibitors in the elimination of B-cell acute lymphoblastic leukemia cells through degradation of HIF-1α
7个月前
已完结
IKZF3 Overexpression Phenocopies Gain-of-Function Mutation in Chronic Lymphocytic Leukemia
8个月前
已完结
IKZF3 Overexpression Phenocopies Gain-of-Function Mutation in Chronic Lymphocytic Leukemia
9个月前
已完结
Critical roles of IKAROS and HDAC1 in regulation of heterochromatin and tumor suppression in T-cell acute lymphoblastic leukemia
9个月前
已关闭
Targeting Activated Signaling Pathways for the Treatment of IKZF1-Deleted B Lymphoblastic Leukemia
11个月前
已关闭
皖公网安备34019202002308
